Chinese wholesale Antiarrhythmic - Dihydroartemisinin Tabs – KeMing Medicines Detail:
| FOB Price | Inquiry |
| Min.Order Quantity | 1,000,000 tablets |
| Supply Ability | 120,000,000 tablets/Month |
| Port | Shanghai |
| Payment Terms | T/T in advance |
| Product Detail | |
| Product name | Dihydroartemisinin Tabs |
| Specification | 60mg |
| Description | A white film-coated tablet |
| Standard | CP |
| Package | 8’s/blister/box |
| Transportation | Ocean,Land,Air |
| Certificate | GMP |
| Price | Inquiry |
| Quality guaranteeperiod | for 36 months |
| Product Description | [Pharmacology] Powerful plasmodicide of malaria parasite agamete which quickly controls symptoms. Highly effective against all forms of malaria including multi_drug resistant malaria. It has high safety and low toxicity.Reproduction toxicology,increase fetal absorption during pregnancy in mice.No mutation effect observed. 60mg for the following 4 or 6 days.See tablet below for children. |
Product detail pictures:

Related Product Guide:
Cholesterol Drugs and Low Vitamin D Along With Other Hormone Levels
Disease, Doctors, Drugs and Vitamins!
We've our have sales staff, style and design staff, technical crew, QC team and package workforce. We've strict excellent control procedures for each system. Also, all of our workers are experienced in printing field for Chinese wholesale Antiarrhythmic - Dihydroartemisinin Tabs – KeMing Medicines, The product will supply to all over the world, such as: Philippines, Miami, Paraguay, Our products are exported worldwide. Our customers are always satisfied with our reliable quality, customer-oriented services and competitive prices. Our mission is "to continue to earn your loyalty by dedicating our efforts to the constant improvement of our items and services in order to ensure the satisfaction of our end-users, customers, employees, suppliers and the worldwide communities in which we cooperate".
Speaking of this cooperation with the Chinese manufacturer, I just want to say"well dodne", we are very satisfied.








